Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,376,277
+$280,445 QoQ
Shares Held
13,294
+5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,911
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Ellis Asset Management LLC holds $17,156,761 across 7 Drug Manufacturers - General names. JNJ ranks #3 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,547 | $4,254,378 | |
| 2 | SNY |
Sanofi
|
81,342 | $3,470,049 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
13,294 | $3,376,277 | |
| 4 | NVS |
Novartis AG
|
14,950 | $2,342,964 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,988 | $1,925,958 | |
| 6 | ABBV |
AbbVie Inc.
|
6,083 | $1,530,726 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,450 | $256,409 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,376,277 | 13,294 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,095,832 | 12,665 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,581,701 | 12,475 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,201,862 | 11,875 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,340,992 | 8,779 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,455,909 | 8,779 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,071,778 | 7,411 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,248,996 | 7,707 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,143,994 | 7,827 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,246,062 | 7,877 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,333,858 | 14,890 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,353,382 | 15,110 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,865,151 | 17,310 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,734,200 | 17,640 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,758,644 | 43,921 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,316,240 | 44,786 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,743,249 | 37,988 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $6,727,119 | 37,957 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $6,251,924 | 36,546 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $5,776,693 | 35,769 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $5,819,111 | 35,323 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,361,988 | 38,710 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $5,453,531 | 34,652 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $5,297,448 | 35,582 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,897,439 | 34,825 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,524,247 | 34,502 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||